Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00362) | |||||
---|---|---|---|---|---|
Name |
Levomilnacipran
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Levomilnacipran; Fetzima; UNII-UGM0326TXX; 96847-54-0; UGM0326TXX; CHEMBL99946; F 2695; (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide; F-2695; (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide; 96847-55-1; Levomilnacipran [USAN:INN]; Milnacipram; (+)-Milnacipran; (1S,2R)-milnacipran; Levomilnacipran (USAN/INN); ZINC506; GTPL7435; SCHEMBL1414867; CHEBI:136040; BDBM50032379; DB08918; SB17447; f2-695; D10072; Q6535779; UNII-G56VK1HF36 component GJJFMKBJSRMPLA-DZGCQCFKSA-N; (1S,2R)-2-Aminomethyl-1-phenyl-cyclopropanecarboxylic acid diethylamide; Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1S,2R)-
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Major depressive disorder | ICD-11: 6A70 | [1] | ||
PubChem CID | |||||
Formula |
C15H22N2O
|
||||
Canonical SMILES |
CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2
|
||||
InChI |
1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m0/s1
|
||||
InChIKey |
GJJFMKBJSRMPLA-DZGCQCFKSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6917779"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 246.35 | Topological Polar Surface Area | 46.3 | |
XlogP | 1.4 | Complexity | 295 | ||
Heavy Atom Count | 18 | Rotatable Bond Count | 5 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Levomilnacipran 120 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Povidone; Ethylcelluloses; Hypromelloses; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Allergan | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Levomilnacipran 20 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Povidone; Ethylcelluloses; Hypromelloses; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Allergan | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Levomilnacipran 40 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide yellow; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Povidone; Ethylcelluloses; Hypromelloses; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Allergan; Avera McKennan Hospital | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Levomilnacipran 80 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Ferric oxide red; Ferrosoferric oxide; Sucrose; Talc; Titanium dioxide; Triethyl citrate; Povidone; Ethylcelluloses; Hypromelloses; Shellac
|
|||||
Dosage Form | 24 HR Extended Release Oral Capsule | |||||
Company | Allergan | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.